Solid tumor proteome and phosphoproteome analysis by high resolution mass spectrometry

S Zanivan, F Gnad, SA Wickström… - Journal of proteome …, 2008 - ACS Publications
Kinases play a prominent role in tumor development, pointing to the presence of specific
phosphorylation patterns in tumor tissues. Here, we investigate whether recently developed …

Mass spectrometry-based proteomics: from cancer biology to protein biomarkers, drug targets, and clinical applications

CR Jimenez, HMW Verheul - American Society of Clinical Oncology …, 2014 - ascopubs.org
Proteomics is optimally suited to bridge the gap between genomic information on the one
hand and biologic functions and disease phenotypes at the other, since it studies the …

Mass spectrometry: uncovering the cancer proteome for diagnostics

DE van der Merwe, K Oikonomopoulou… - Advances in Cancer …, 2006 - Elsevier
Despite impressive scientific achievements over the past few decades, cancer is still a
leading cause of death. One of the major reasons is that most cancer patients are diagnosed …

An integrative analysis of tumor proteomic and phosphoproteomic profiles to examine the relationships between kinase activity and phosphorylation

OA Arshad, V Danna, VA Petyuk, PD Piehowski… - Molecular & Cellular …, 2019 - ASBMB
Phosphorylation of proteins is a key way cells regulate function, both at the individual protein
level and at the level of signaling pathways. Kinases are responsible for phosphorylation of …

Frontiers in mass spectrometry–based clinical proteomics for cancer diagnosis and treatment

Y Haga, Y Minegishi, K Ueda - Cancer Science, 2023 - Wiley Online Library
Numerous omics studies, primarily genomics analyses, have been conducted to fully
understand the molecular biological characteristics of cancer. In recent years, the depth of …

Mass spectrometry based proteomics profiling as diagnostic tool in oncology: current status and future perspective

P Findeisen, M Neumaier - Clinical chemistry and laboratory …, 2009 - degruyter.com
Proteomics analysis has been heralded as a novel tool for identifying new and specific
biomarkers that may improve diagnosis and monitoring of various disease states. Recent …

Advances in proteomic technologies and its contribution to the field of cancer

M Mesri - Advances in medicine, 2014 - Wiley Online Library
Systematic studies of the cancer genome have generated a wealth of knowledge in recent
years. These studies have uncovered a number of new cancer genes not previously known …

Clinical applications of mass spectrometry‐based proteomics in cancer: Where are we?

EL Boys, J Liu, PJ Robinson, RR Reddel - Proteomics, 2023 - Wiley Online Library
Tumor tissue processing methodologies in combination with data‐independent acquisition
mass spectrometry (DIA‐MS) have emerged that can comprehensively analyze the …

Quantitative proteomics and biomarker discovery in human cancer

Y Zhao, WNP Lee, GG Xiao - Expert review of proteomics, 2009 - Taylor & Francis
Early diagnosis and prevention is crucial for reducing the mortality and morbidity of cancer.
Current clinical examination, such as mammography and invasive needle or surgical …

Proteomics strategies for target identification and biomarker discovery in cancer.

U Rajcevic, SP Niclou, CR Jimenez - Frontiers in bioscience-Landmark, 2009 - orbilu.uni.lu
The revolution in genomics and proteomics has produced complex technologies enabling
an insight into the functional effectors of cellular processes. In oncology these technologies …